INTELLECT NEUROSCIENCES INC
Business Summary
Intellect Neurosciences, Inc is a United States-based company, which operates as a biopharmaceutical company. The Company is engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of rare, neurodegenerative, orphan diseases with no approved therapies. The Company is focused on developing each compound and licenses the compounds to pharmaceutical companies for development and commercialization. Its product pipeline consists of SHP622, Anti-Tauc3 Monoclonal Antibody and Conjumab-A: Antibody Drug Conjugate. SHP622 is indicated for the treatment of Friedreich's Ataxia and Other Neurodegenerative Disorders. Anti-Tauc3 Monoclonal Antibody is indicated for the treatment of progressive supranuclear palsy, traumatic brain injury and other Tauopathies. Conjumab-A: Antibody Drug Conjugate is indicated for the treatment of age-related macular degeneration.
Country of Incorporation
United States of America
Incorporation Date
2007-01-24
Business Sector
Pharmaceuticals & Medical Research
Company Address
SUITE 101, 550 SYLVAN AVENUE
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
